You are here

Renal Ünitelerce Bilinen Hastalar Kronik Hemodiyalize Nasıl Başlar?

How do Patients who are Known to the Renal Units Start Chronic Haemodialysis?

Journal Name:

Publication Year:

DOI: 
10.5262/tndt.2011.1003.04

Keywords (Original Language):

Abstract (2. Language): 
INTRODUCTION: A signifi cant number of known ESRD patients start dialysis as an emergency. Key factors that determine emergency dialysis initiation have not been well identifi ed. MATERIAL and METHODS: Ninety out of 159 patients studied were known for> 6 months and divided into Emergency dialysis (EmG n=46) and Elective dialysis (EG n=44) groups. RESULTS: Most diabetic patients started dialysis as an emergency (75% vs. 25% p=0.008). At the start, EmG had higher median urea (3.5 vs. 3.8 g/dl p=0.05), a lower bicarbonate (19 vs. 21.5 mEq/L, p=0.04) and haemoglobin (9.4 vs10.5 g/dl p=0.005). Three months pre-dialysis, EmG had a lower serum albumin (3.2 vs. 3.6 g/L, p=0.001) and haemoglobin (10.4 vs. 11, p=0.06), a higher CRP (21 vs. 5, p=0.08) and better preserved eGFR (11 vs. 9, p=0.001). In multivariate analysis, only a diagnosis of diabetes and a CRP >30 were independent risk factors for starting dialysis as an emergency. Having an albumin >3.5 was associated with a reduced risk of having an emergency start to dialysis. CONCLUSION: Apart from having diabetes, it seems diffi cult to predict emergency start of dialysis in known ESRD patients. Randomised controlled studies can further identify importance of high CRP and low serum albumin in relation to emergency initiation of dialysis.
Abstract (Original Language): 
GİRİŞ: SDBY bulunduğu bilinen hastaların önemli bir kısmı diyalize acil şartlarda başlar. Diyalize acil şartlarda başlamayı belirleyen ana faktörler henüz tanımlanmamıştır. GEREÇ ve YÖNTEMLER: Çalışılan 159 hastanın 90’ı > 6 aydır bilinmekteydi ve Acil diyaliz (EmG n=46) ve Elektif diyaliz (EG n=44) gruplarına bölündü. BULGULAR: Çoğu diyabetik hasta diyalize acil şartlarda başladı (%75 ve %25, p=0,008). Başlangıçta EmG grubunda medyan üre (3,5 ve 3,8 g/dl, p=0,05) daha yüksekti, bikarbonat (19 ve 21,5 mEq/L, p=0,04) ve hemoglobin (9,4 ve 10,5 g/dl, p=0,005) ise daha düşüktü. Diyalizden 3 ay önce EmG grubunda serum albumin (3,2 ve 3,6 g/L, p=0,001) ve hemoglobin (10,4 ve 11, p=0,06) daha düşüktü, CRP (21 ve 5, p=0,08) daha yüksekti ve eGFR (11 ve 9, p=0,001) daha iyi korunmuştu. Multivaryant analizde sadece diyabet tanısı ve CRP >30 diyalize acil şartlarda başlamak açısından bağımsız risk faktörleriydi. Albumin düzeyinin >3,5 g/L olması diyalize acil şartlarda başlanması riskinde bir azalmayla ilişkiliydi. SONUÇ: Bilinen SDBY hastalarında diyabetli olmak dışında diyalize acil şartlarda başlanmasını öngörmek zor görünmektedir. Randomize kontrollü çalışmalar diyalize acil şartlarda başlanması açısından yüksek CRP ve düşük serum albumini bulunmasının önemini daha iyi tanımlayabilir.
227-234

REFERENCES

References: 

1. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche
T, Man NK: Late referral to maintenance dialysis: detrimental
consequences. Nephrol Dial Transplant 1993; 8: 1089-1093
2. Roderick P, Jones C, Tomson C, Mason J: Late referral for dialysis:
Improving management for chronic renal disease.QJM 2002; 95:
363-370
3. Innes A, Rowe PA, Burden RP, Morgan AG: Early death on renal
replacement therapy: The need for early nephrological referral.
Nephrol Dial Transplant 1992; 7: 467-471
4. Lameire N, Van Biesen W: The pattern of referral of patients
with ESRD to the nephrologists a European survey. Nephrol Dial
Transplant 1999; 14(Suppl 6): 16-23
Raza M and Dudley C : Dialysis Initiation in ESRD
Turk Neph Dial Transpl 2011; 20 (3): 227-234
234
Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
Turkish Nephrology, Dialysis and Transplantation Journal
5. Buck J, Baker R, Cannaby AM, Nicholson S, Peters J, Warwick
G: Why do patients known to renal services still undergoes urgent
dialysis initiation? A cross-sectional survey. Nephrol Dial Transplant
2007; 22(11):3240-3245
6. Ansell D, Feest T, Hodsman A, Rao R, Tomson C, Udayaraj U,
Williams A, Warwic G, Caskey F, Farrington K, Fluck R, Harper
J, Lamb E, Lewis M, Macdonald J, Ravanan R, Richardson D,
Thomas D: The Ninth Annual Report: UK Renal Registry, 2006
7. Mendelssohn DC, Toffelmire EB, Levin A: Attitudes of Canadian
nephrologists toward multidisciplinary team- based CKD clinic
care. Am J Kidney Dis 2006; 47(2): 277-284
8. Department of Health Renal Team: National Service Framework
for renal services- part one: Dialysis and Transplantation 2004
(www.dh.gov.uk/renal)
9. Chesser A M, Baker L R: Temporary vascular access for fi rst dialysis
is common, undesirable and usually avoidable. Clin Nephrol 1999;
51(4): 228-232
10. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL:
Haemodialysis vascular access problems in Canada: Results from
the Dialysis Outcomes and Practice Patterns Study (DOPPS II).
Nephrol Dial Transplant 2006; 21(3): 721-728
11. Hakim RM, Lazarus JM: Initiation of dialysis. J Am Soc Nephrol
1995; 6(5): 1319-1328
12. Poursh JG, Faubert PF: Chronic renal failure. In Renal Disease in
the aged. Boston (MA) : Little Brown, 1991; 285-313
13. David N Churchill: An Evidence-based approach to earlier initiation
of dialysis. Am J Kidney Dis 1997; 30(6): 899-906
14. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel
MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore
A, Tiller DJ, Harris DC, Pollock CA; IDEAL Study: IDEAL study, a
randomised, controlled trial of early versus late initiation of dialysis.
NEJM 2010, 363: 609-619
15. Stenvinkel P, Alvestrand A: Infl ammation in end-stage renal disease:
sources, consequences, and therapy. Sem Dial 2002; 15: 329-337
16. Kaysen GA: The microinfl ammatory state in uraemia: causes and
potential consequences. J Am Soc Nephrol. 2001; 12: 1549-1557
17. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C:
Prognostic value of combined use of biomarkers of infl ammation,
endothelial dysfunction and cardiomyopathy in patients with ESRD.
Kidney Int 2005; 67: 2330-2337
18. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ,
Kusek JW, Collins AJ, Levey AS, Sarnak MJ: C-reactive protein
and albumin as predictors of all-cause and cardiovascular mortality
in chronic kidney disease. Kidney Int 2005; 68:766-772
19. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ,
Kusek JW, Collins AJ, Levey AS, Sarnak MJ: C-reactive protein
and albumin as predictors of all-cause and cardiovascular mortality
in chronic kidney disease. Kidney Int 2005; 68(2): 766-772
20. Soriano S, González L, Martín-Malo A, Rodríguez M, Aljama P:
C-reactive protein and low albumin are predictors of morbidity and
cardiovascular events in chronic kidney disease (CKD) 3-5 patients.
Clin Nephrol 2007; 67(6): 352-357

Thank you for copying data from http://www.arastirmax.com